[1]
Kurniawan, J., Handayu, A.D., Aprilicia, G., Bahri, D.R. and Hasan, I. 2025. Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients. Acta Medica Indonesiana. 56, 4 (Jan. 2025), 451.